Back to Top Skip to main content

The Defense Health Agency participates in AUSA 2019 annual meeting

U.S. Army Lt. Gen. Ronald Place, DHA Director, discusses upcoming Military Health System changes designed to improve the readiness of combat forces during a seminar held at the Association of the United States Army 2019 Annual Meeting and Exposition in Washington, D.C.  Lt. Gen. Place explained how DHA is standardizing systems to improve healthcare across the enterprise.  (DHA Photo by Hannah Wagner) U.S. Army Lt. Gen. Ronald Place, DHA Director, discusses upcoming Military Health System changes designed to improve the readiness of combat forces during a seminar held at the Association of the United States Army 2019 Annual Meeting and Exposition in Washington, D.C. Lt. Gen. Place explained how DHA is standardizing systems to improve healthcare across the enterprise. (DHA Photo by Hannah Wagner)

Recommended Content:

Health Readiness | Preventive Health

WASHINGTON – The Defense Health Agency participated in the Association of the United States Army’s 2019 Annual Meeting and Exposition in Washington, D.C., Oct. 14-16. The exposition brought together service members and civilians to discuss the future of the Army and national defense, allowing DHA to highlight its role in keeping soldiers healthy and ready for battle through the Military Health System.

The MHS supports more than 9.4 million beneficiaries, including active duty service members, their families, and military retirees. The conference allowed DHA to showcase how the agency supports beneficiaries through a worldwide network of military treatment facilities and purchased-care options.

The annual exposition featured seminars and panel discussions on pertinent military and national security subjects, and dozens of professional development events that included key leaders from the Army, DoD, and Congress.

During one seminar, Army Lt. Gen. Ronald Place, director of the DHA, shared his view of the future of the Military Health System and health care for military families. Place emphasized how the agency is standardizing procedures across the MHS to provide quality, patient-centered care for all beneficiaries.

“The number-one objective in the Defense Health Agency,” Place said, “is to get from where we are now, developing local solutions to solve problems, to a standardized system where it all makes sense. We are standardizing our systems to better support all of you.”

In another seminar, U.S. Navy Capt. Edward Simmer, TRICARE Health Plan chief clinical officer, discussed upcoming changes to the TRICARE health benefit, and highlighted how beneficiaries can make changes to their health care plans during the upcoming TRICARE Open Season, Nov. 11 – Dec. 9.

Simmer also explained that the AUSA conference provided the opportunity to interact with beneficiaries who may have questions about their TRICARE benefits.

“It’s a very good way for us to get the word out about pending changes,” Simmer said. “Plus, [we receive] information through their questions and comments about what’s working, what’s not working, and what changes they’d like to see. That helps us shape the benefits going forward.”

TRICARE beneficiaries can learn more about their benefits through TRICARE’s website.

The conference also provided an opportunity to demonstrate how the MHS has contributed to health care innovation by harnessing state-of-the-art technology. During the conference, DHA exhibited a three-dimensional, multimaterial printer used by the Uniformed Services University for Health Sciences to demonstrate how bioprinting could solve medical logistics challenges in austere combat environments of the future.

Dr. Vincent Ho, professor and chair of the Department of Radiology and Radiological Sciences at USU, explained how 3D printers have manufactured scalpel handles and hemostats, bioactive bandages, and surgical models of a T9 vertebrae and a meniscus.

“We got a lot of interest from conference attendees on how we’re using biomanufacturing in the field,” Ho said. “It’s great exposure to show what USU is working on in medical science.”

As the DHA continues to innovate the future of military medicine, Place assured conference attendees that their care remains a top priority, encouraging them to ask questions and provide feedback on the system.

“The Military Health System gets better every day,” said Place, “because every single leader…is universally aligned in the idea that what we do matters to you.”

You also may be interested in...

DHA IPM 19-006: 2019–2020 Seasonal Influenza Vaccination Program (IVP)

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (o), implementing instructions, assigns responsibilities, and prescribes procedures for the seasonal influenza vaccination program. • This DHA-IPM cancels and reissues DHA-IPM 18-005. • This DHA-IPM is effective immediately and will expire 12 months from the date of issue.

DHA IPM 19-003: Reserve Health Readiness Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (i): • Provides utilization guidance and funding requirements for the RHRP contract to supplement Reserve Component Individual Medical Readiness (IMR) and Deployment Health activities when Service organic health readiness resources are not available to meet mission requirements. • Provides utilization guidance and funding requirements for the RHRP contract for Active Duty enrolled in TRICARE Prime Remote, U.S. Coast Guard (USCG), USCG Reserves, and re-deploying DoD civilians (e.g., U.S. Army Corps of Engineers and U.S. Army Intelligence and Security Command). • Communicate procedure guidance to all DoD organizations utilizing RHRP services. • Will expire effective 12 months from the date of issue and be converted to a DHA-Procedural Instruction.

  • Identification #: 19-003
  • Date: 3/8/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Health Readiness

DHA PI 6025.07: Naloxone in the MTFs

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.

DHA PI 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the procedures for the FHPQA Program as defined in Reference (z). This DHA-PI applies to: a. OSD, the Military Departments (including the United States Coast Guard (USCG) at all times, including when it is a Service in the Department of Homeland Security by agreement with that Department), the Office of the Chairman of the Joint Chiefs of Staff (CJCS) and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the DoD, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD (referred to collectively in this DHA-PI as the “DoD Components”). b. Civilian personnel, as defined in Reference (e), and DoD contractor personnel authorized to accompany the force (CAAF), in accordance with References (j), (m), and (n), respectively.

  • Identification #: DHA PI 6200.05
  • Date: 5/2/2018
  • Type: DHA Procedural Instruction
  • Topics: Health Readiness

DoD Instruction 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This issuance establishes policy, assigns responsibilities, and defines requirements for the development and establishment of the FHPQA Program in accordance with the authority in DoD Directive (DoDD) 5124.02, Sections 731 and 738 of Public Law 108-375; Sections 1074f, 1092a, and 1073b of Title 10, United States Code; and DoDDs 6200.04 and 5136.13.

DoD Instruction 6490.13: Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

Policy

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Policy

Guidance as of 17 OCT 2014 from the Department of Defese (AFHSC)for Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

DoD Instruction 1010.10: Health Promotion and Disease Prevention

Policy

This instruction reissues DoD Directive (DoDD) 1010.10 (Reference (a)) as a DoD instruction (DoDI) in accordance with the authority in DoDD 5124.02 (Reference (b)) to establish policy and assign responsibilities for health promotion and disease prevention in accordance with References (c) through (f).

  • Identification #: DoD Instruction 1010.10
  • Date: 4/28/2014
  • Type: Instructions
  • Topics: Preventive Health

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

DoD Laboratories Participating in CDC Laboratory Response Network 03-213

Policy

Department of Defense (DoD) laboratories participating in the Centers for Disease Control and Prevention-sponsored Laboratory Response Network (LRN) do so with the approval and support of their respective Military Department Surgeons General.

  • Identification #: 03-213
  • Date: 3/26/2013
  • Type: Memorandums
  • Topics: Health Readiness

Medical Planning and Programming Lexicon

Policy

DoD Instruction Number 6490.11: DoD Policy Guidance for Management of Mild Traumatic Brain Injury/Concussion in the Deployed Setting

Policy

This instruction establishes policy, assigns responsibilities, and provides procedures on the management of mild traumatic brain injury (mTBI), also known as concussion, in the deployed setting.

Access to Medical Services Who were Exposed to Rabies in Combat Theater

Policy
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.